271 related articles for article (PubMed ID: 24428606)
21. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function.
Eriksson S; Lindell SE; Wiberg R
Eur J Respir Dis; 1985 Oct; 67(4):279-85. PubMed ID: 3878302
[TBL] [Abstract][Full Text] [Related]
22. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
[TBL] [Abstract][Full Text] [Related]
23. Interaction of Cigarette Smoking and Polygenic Risk Score on Reduced Lung Function.
Kim W; Moll M; Qiao D; Hobbs BD; Shrine N; Sakornsakolpat P; Tobin MD; Dudbridge F; Wain LV; Ladd-Acosta C; Chatterjee N; Silverman EK; Cho MH; Beaty TH
JAMA Netw Open; 2021 Dec; 4(12):e2139525. PubMed ID: 34913977
[TBL] [Abstract][Full Text] [Related]
24. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
[TBL] [Abstract][Full Text] [Related]
25. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
Stockley RA; Edgar RG; Pillai A; Turner AM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
[TBL] [Abstract][Full Text] [Related]
26. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
Silverman EK; Mosley JD; Rao DC; Palmer LJ; Province MA; Elston RC; Weiss ST; Campbell EJ
Hum Hered; 2001; 52(4):223-32. PubMed ID: 11713419
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneous burden of lung disease in smokers with borderline airflow obstruction.
Pirozzi CS; Gu T; Quibrera PM; Carretta EE; Han MK; Murray S; Cooper CB; Tashkin DP; Kleerup EC; Barjaktarevic I; Hoffman EA; Martinez CH; Christenson SA; Hansel NN; Graham Barr R; Bleecker ER; Ortega VE; Martinez FJ; Kanner RE; Paine R;
Respir Res; 2018 Nov; 19(1):223. PubMed ID: 30454050
[TBL] [Abstract][Full Text] [Related]
28. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
[TBL] [Abstract][Full Text] [Related]
29. Α₁-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease.
Goltz D; Hittetiya K; Vössing LM; Kirfel J; Spengler U; Fischer HP
Virchows Arch; 2014 Nov; 465(5):539-46. PubMed ID: 25070245
[TBL] [Abstract][Full Text] [Related]
30. Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
Carleo A; Chorostowska-Wynimko J; Koeck T; Mischak H; Czajkowska-Malinowska M; Rozy A; Welte T; Janciauskiene S
Int J Chron Obstruct Pulmon Dis; 2017; 12():829-837. PubMed ID: 28331304
[TBL] [Abstract][Full Text] [Related]
31. Exhaled nitric oxide levels in alpha-1-antitrypsin PiMZ subjects.
Malerba M; Ragnoli B; Radaeli A
J Intern Med; 2009 Mar; 265(3):382-7. PubMed ID: 19019191
[TBL] [Abstract][Full Text] [Related]
32. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ.
Seersholm N; Wilcke JT; Kok-Jensen A; Dirksen A
Am J Respir Crit Care Med; 2000 Jan; 161(1):81-4. PubMed ID: 10619801
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal lung function study in heterozygous PiMZ phenotype subjects.
Tarján E; Magyar P; Váczi Z; Lantos A; Vaszár L
Eur Respir J; 1994 Dec; 7(12):2199-204. PubMed ID: 7713204
[TBL] [Abstract][Full Text] [Related]
34. Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency.
Bernspång E; Sveger T; Piitulainen E
Respir Med; 2007 Sep; 101(9):1971-6. PubMed ID: 17532199
[TBL] [Abstract][Full Text] [Related]
35. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
[TBL] [Abstract][Full Text] [Related]
36. Genes and chronic obstructive pulmonary disease.
Foreman MG; Campos M; Celedón JC
Med Clin North Am; 2012 Jul; 96(4):699-711. PubMed ID: 22793939
[TBL] [Abstract][Full Text] [Related]
37. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
[TBL] [Abstract][Full Text] [Related]
38. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
39. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
40. [The variability of clinical presentation of chronic obstructive pulmonary disease in patients with hereditary alpha-1 antitrypsin deficiency].
Kuca P; Kamiński D; Campbell E; Kołakowski J; Goljan-Geremek A; Puścińska E; Bieleń P; Nowiński A; Wojda E; Hawryłkiewicz I; Sliwiński P; Górecka D
Pneumonol Alergol Pol; 2004; 72(9-10):420-3. PubMed ID: 16021998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]